Literature DB >> 20054307

Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis.

Guadalupe Garcia-Tsao, Christina M Surawicz.   

Abstract

The development of Clostridium difficile infection in cirrhosis is predictive of death, independent of severity of liver disease. The main risk factors are the use of antibiotics and proton-pump inhibitors (PPIs). This is further evidence that supports the wise and cautious use of antibiotics in cirrhosis and suggests avoiding the use of PPIs in these patients except for indications of proven benefit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054307     DOI: 10.1038/ajg.2009.604

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

Review 1.  Bacterial infections in cirrhosis: A critical review and practical guidance.

Authors:  Chalermrat Bunchorntavakul; Naichaya Chamroonkul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2016-02-28

2.  Outcomes among inpatients with cirrhosis and Clostridioides difficile infection in the modern era: results from an analysis of the National Inpatient Sample.

Authors:  Sentia Iriana; Sachit Sharma; Stephanie McDonough; Eduardo Rodriguez Zarate; Douglas G Adler
Journal:  Ann Gastroenterol       Date:  2021-06-14

Review 3.  Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review.

Authors:  Yuanbin Liu; Mingkai Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-07

4.  Outcomes associated with Clostridium difficile infection in patients with chronic liver disease.

Authors:  Kierra M Dotson; Samuel L Aitken; Amelia K Sofjan; Dhara N Shah; Rajender R Aparasu; Kevin W Garey
Journal:  Epidemiol Infect       Date:  2018-05-09       Impact factor: 4.434

5.  Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.

Authors:  Yao-Wen Cheng; Dana Alhaffar; Srishti Saha; Sahil Khanna; Matthew Bohm; Emmalee Phelps; Marwan Ghabril; Eric Orman; Sagi Sashidhar; Nicholas Rogers; Huiping Xu; Alexander Khoruts; Byron Vaughn; Dina Kao; Karen Wong; Giovanni Cammarota; Gianluca Ianiro; Tanvi Dhere; Colleen S Kraft; Nirja Mehta; Michael H Woodworth; Jessica R Allegretti; Lotem Nativ; Jenna Marcus; Najwa El-Nachef; Monika Fischer
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-06       Impact factor: 13.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.